Gland Pharma Ltd - 543245 - Board Meeting Intimation for Board Meeting Intimation For Quarterly Board Meeting
Gland Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2021 ,inter alia, to consider and approve the Unaudited financial results of the Company for the quarter and nine months ended December 31, 2020 Gland Pharma's growth trajectory to remain elevated in medium term
Margin expansion to support profits, clean regulatory track record to help sustain growth journey Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst/ Investor meeting with Anand Rathi, Concept Investwell Pvt. Ltd. and Kotak Institutional Equities on December 26 and 28, 2020 Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet with IIFL Institutional Equities on 23-Dec-2020 Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor Meet with Arohi Asset Management Pte. Ltd on 22-Dec-2020 Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst / Investor meeting with Franklin Templeton Investments on 17-Dec-2020 Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Analyst /Institutional Investor Meetings Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Institutional Investor Meeting Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Investor Meetings (One on One) with various Investors Gland Pharma Ltd - 543245 - Shareholding for the Period Ended November 17, 2020
Gland Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended November 17, 2020. For more details, kindly Click here